FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
15 letters match. Newest first.
-
DrugsTCI Co., Ltd BioCosme PABP BRANCH
FDA warns Taiwan OTC drug contract manufacturer TCI BioCosme over CGMP violations, including incomplete release and ingredient testing.
High risk -
FoodH2 BEV, LLC and H2 RENU, INC
FDA warns H2 BEV and H2 RENU over unregistered acidified hydrogen beverages with unmonitored pasteurization and drug claims.
High risk -
DrugsIDO Pharm Co., Ltd.
IDO Pharm, South Korean drug manufacturer, cited for good manufacturing practice violations including unvalidated system and test methods.
High risk -
DrugsPatcos Cosmetics Pvt. Ltd.
Patcos Cosmetics, an Indian OTC drug manufacturer, was cited for insanitary conditions and CGMP violations after a 2025 FDA inspection.
High risk -
DevicesExactech, Inc. dba Advita Ortho
FDA warned Exactech/Advita Ortho over quality-system failures in Equinoxe shoulder implants found during a July 2025 Sarasota inspection.
High risk -
FoodChristopher Dale Butler
FDA warned Christopher Dale Butler that his pickled quail egg products lacked required acidified-food process controls and were deemed adulterated (unsafe under the law).
High risk -
DrugsMedinatura New Mexico, Inc.
FDA cited Medinatura New Mexico for drug manufacturing rule violations, including weak component testing and cleaning.
High risk -
Drugs3D Imaging Drug Design and Development LLC
FDA warns 3D Imaging of CGMP failures in sterile PET drug manufacturing and outdated drug listings.
High risk -
DrugsPQ Pharmacy, LLC
FDA warns PQ Pharmacy, a Florida sterile drug compounder, that its products were made under unsafe conditions.
High risk -
DrugsTaizhou Kangping Medical Science and Technology Co., Ltd.
FDA warns Taizhou Kangping about over-the-counter drugs labeled sterile that were not sterilized.
High risk -
DrugsAcme United Corporation
Acme United Corporation made antiseptic wipes with contaminated water and released sterile drugs without sterility testing.
High risk -
DrugsHealth and Natural Beauty USA Corp.
FDA warns Health and Natural Beauty USA over CGMP failures and unapproved, misbranded SprinJene OTC toothpastes, including children’s products.
High risk -
DrugsEverlaan Organics, Inc. dba Maple Organics
FDA warns Maple Organics over OTC drug CGMP failures, unapproved new drugs, and misbranding.
High risk -
DrugsOasis Medical, Inc.
FDA cites Oasis Medical for current good manufacturing practice violations in sterile ophthalmic drugs, including particulate contamination and unresolved sterility failures.
High risk -
DrugsMedical Chemical Corporation
FDA warned Medical Chemical Corp over manufacturing violations, unapproved Tincture Green Soap, and improper drug listing.
High risk